Advances in the Understanding of Etiology, Evaluation, and Management of Neurotrophic Keratitis
Complimentary
Released on 3/5/25
Expires on 3/5/26
Program Description
This enduring webcast program aims to enhance healthcare professionals’ understanding of neurotrophic keratitis (NK). Participants will explore the etiology, pathophysiology, and recommended screening and diagnostic procedures essential for establishing an accurate NK diagnosis. Furthermore, the program will evaluate the efficacy and clinical utility of both current and emerging treatments, providing insights into managing NK across its early and late stages. Through this comprehensive educational experience, clinicians will be better equipped to improve patient outcomes in NK care.
Intended Audience
Ophthalmologists, optometrists, and advanced practice providers (physician assistants and nurse practitioners) who manage patients with neurotrophic keratitis (NK)
Commercial Supporter
This activity is supported by an educational grant from Dompé US Inc.
Learning Objectives
- Summarize the etiology, pathophysiology, recommended screening, and testing procedures used to establish a diagnosis of NK
- Assess the efficacy and clinical utility of current and emerging treatments for the early- and late-stage NK
Accredited Providers
This activity is provided by Amedco and MedNet.

Joint Accreditation Statement

In support of improving patient care, Amedco and MedNet have planned and implemented this activity. Amedco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. MedNet serves as the content and logistic provider for this activity.
Physicians Credit Designation
Amedco designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Additional Credit Information
Physician Assistants
AAPA accepts AMA PRA Category 1 CreditTM for the PRA from organizations accredited by ACCME. Maximum of 1.25 hours.
Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors, and allows reciprocity for AANPCP continuing education credit. Maximum of 1.25 hours.
Through an agreement between the American Medical Association (AMA) and the European Union of Medical Specialists, physicians and healthcare providers may convert CME/CE PRA Category 1 CreditsTM to an equivalent number of European CME Credits® (ECMECs®). The UEMS-EACCME® has recognition agreements with the AMA for live events and e-learning materials.
Faculty
Walter Whitley, OD, MBA, FAAO
Virginia Eye Consultants
Norfolk, VA
Dr. Whitley discloses the following:
Advisory Board Member: Alcon, Allergan, Bausch and Lomb, Bruder Healthcare, Science Based Health, Sun Pharmaceuticals, Tarsus Pharmaceuticals, Visus Pharmaceuticals
Consultant: Alcon, Aldeyra Therapeutics, Allergan, Apellis Pharmaceuticals, CSI Dry Eye Inc., Epion, Glaukos, Harrow, 12-Vision, Inc., Iveric Bio, Mediprint Pharma, Nordic Pharma, OD Immersion, Regener-Eyes, Sight Sciences, Thea Pharmaceuticals, Trukera, Viatris
Speaker: Alcon, Allergan, Apellis Pharmaceuticals, Bausch and Lomb
Co-Chief Medical Editor: Modern Optometry
Contributing Editor: Review of Optometry
Co-Medical Editor: Dry Eye Coach
Stephen C. Pflugfelder, MD
Professor and James and Margaret Elkins Chair in Ophthalmology
Baylor College of Medicine
Houston, TX
Dr. Pflugfelder discloses the following:
Consultant: Alcon, Dompe, Kala, and Kow
Instructions
In order to receive CME/CE credits, participants must complete the pre-assessment questions, post-assessment, and program evaluation. Participants must also score at least 75% on the post-assessment. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Dashboard or Transcript, which you can access at any time.
ACCME – Amedco
Phone Number: 651-789-3730
E-Mail: justin@amedcoemail.com
Privacy Policy
Webcast
Time to Complete: 75 minutes
Released: March 5, 2025
Expires: March 5, 2026
Maximum Credits:
1.25 / AMA PRA Category 1 CreditsTM
Related products
-

Sustained-Release Drug Delivery System in the Management of Glaucoma
Read more -

Advances in Biological Therapies for Atopic Dermatitis in Adults and Children
Read more -

Advances in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease
Read more -

Ocular Surface Disease: Pathophysiology, Evaluation, Management with Topical Agents, and Neuromodulation
Read more




